Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yulianti Susilo"'
Publikováno v:
Economics & Business Quarterly Reviews. Jun2023, Vol. 6 Issue 2, p109-120. 12p.
Publikováno v:
Majalah Kedokteran Bandung, Vol 51, Iss 2, Pp 95-103 (2019)
Rituximab is a chimeric monoclonal antibody which has specific for CD20 antigen expressed by pre-B and mature B-cells. Radiolabelled Rituximab, 131I-Rituximab, has been sucessfully used for treatment of B-Cell NHL. Due to its short shelf-life, 131I-R
Externí odkaz:
https://doaj.org/article/6cddca231d6d422081824cf1b7a7f7b7
Autor:
Rien Ritawidya, Citra Rezza Aurora Putri Palangka, Titis Sekar Humani, Veronika Yulianti Susilo, Ilma Darojatin, Anung Pujiyanto
Publikováno v:
Indonesian Journal of Pharmacy. :333-352
Somatostatin receptors (SSTRs) are overexpressed in a wide variety of cancers such as neuroendocrine tumors (NETs), but the expression in normal cells is relatively low. Therefore, SSTRs serve a potential target for molecular imaging and therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b0e106d5c11fd359c99793a1a034af
https://doi.org/10.22146/ijp.2514
https://doi.org/10.22146/ijp.2514
Autor:
Basuki Hidayat, Stepanus Massora, Martalena Ramli, Veronika Yulianti Susilo, Agus Arianto, Johan S. Masjhur
Publikováno v:
Majalah Kedokteran Bandung, Vol 48, Iss 1, Pp 39-44 (2016)
The development of therapeutic drug for malignancy in Indonesia is often constrained because of the inability to provide animal models for preclinical study. These animal models are an animal model with a malignancy mass which have special characteri
Externí odkaz:
https://doaj.org/article/8564819c3be94b7b94d46a242a8d6908
Autor:
Maria Christina Prihatiningsih, Teguh Ariyanto, Edy Giri Rachman Putra, Veronika Yulianti Susilo, Isa Mahendra, Imam Prasetyo
Publikováno v:
ACS Omega. 7:13494-13506
There are challenges related to cancer treatment, namely, targeting and biocompatibility associated with a drug vehicle. This research aims to prepare a theranostic cancer vehicle based on porous silica nanoparticles (PSN) with controllable nanoparti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe036ae120cd5d283cc673d486d77367
https://doi.org/10.1021/acsomega.1c06492
https://doi.org/10.1021/acsomega.1c06492
Publikováno v:
Majalah Kedokteran Bandung, Vol 51, Iss 2, Pp 95-103 (2019)
Rituximab is a chimeric monoclonal antibody which has specific for CD20 antigen expressed by pre-B and mature B-cells. Radiolabelled Rituximab, 131 I-Rituximab, has been sucessfully used for treatment of B-Cell NHL. Due to its short shelf-life, 131 I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b361b64ee00e0f3e5f8a701dff56da1a
https://doi.org/10.15395/mkb.v51n2.1595
https://doi.org/10.15395/mkb.v51n2.1595
Autor:
Muhammad Yusuf, Galih Dwi Pramono, Zuhrotun Nafisah, Ade Rizqi Ridwan Firdaus, Ari Hardianto, Veronika Yulianti Susilo, Rustaman Rustaman, Abdul Mutalib, Ukun MS Soedjanaatmadja
Publikováno v:
Indonesian Journal of Computational Biology (IJCB). 1:22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b937a2f8bcc599c5d645b2a01ad7a443
https://doi.org/10.24198/ijcb.v1i1.41599
https://doi.org/10.24198/ijcb.v1i1.41599
Publikováno v:
Open Access Macedonian Journal of Medical Sciences; Vol. 8 No. B (2020): B-Clinical Sciences; 1064-1070
BACKGROUND: Iodine can reduce breast tumor progression by mediates an antiproliferative effect. AIM: This study aimed to investigate the effect of iodine (I2), Lugol (I3K), and the combination of both on cell proliferation of three different types of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922092b713fde762a7a016bc79f03401
https://www.id-press.eu/mjms/article/view/5447
https://www.id-press.eu/mjms/article/view/5447
Autor:
Agus Arianto, Martalena Ramli, Veronika Yulianti Susilo, Basuki Hidayat, Johan S. Masjhur, Stepanus Massora
Publikováno v:
Majalah Kedokteran Bandung, Vol 48, Iss 1, Pp 39-44 (2016)
Pengembangan obat terapi keganasan di Indonesia sering kali terkendala karena ketidakmampuan menyediakan hewan model untuk uji preklinis. Hewan model tersebut adalah hewan model dengan massa keganasan yang mempunyai karakteristik khusus, bukan sekeda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d7e01f9747171b5662726d7aa3d278
http://journal.fk.unpad.ac.id/index.php/mkb/article/view/732
http://journal.fk.unpad.ac.id/index.php/mkb/article/view/732
Autor:
Yunilda Alwi, Sri Setiowati, Veronika Yulianti Susilo, Rohadi Awaludin, Widyastuti Widjaksana
Publikováno v:
Jurnal Kefarmasian Indonesia, Vol 7, Iss 1, Pp 19-25 (2017)
Penyakit kanker merupakan salah satu penyebab kematian utama di seluruh dunia. Pada tahun 2012, kanker menjadi penyebab kematian sekitar 8,2 juta orang. Kanker paru, kanker hati, kanker perut, kanker kolorektal, dan kanker payudara adalah penyebab te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ad0e78cb6d3406ebafafd888d81666
https://doi.org/10.22435/jki.v7i1.5304.19-25
https://doi.org/10.22435/jki.v7i1.5304.19-25